DocGo Akcija

DocGo EBITDA

Vrijednost EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od DocGo (DCGO) na dan 21. авг 2026. je 44,57 М USD. Prethodne godine, EBITDA (Заработак пре камата, пореза, амортизације и отписивања) je bio 31,75 М USD — promjena od 40,38% (viši).

EBITDA

44,57 МUSD

YoY

40,38%

Zadnja ažuriranja:

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od DocGo je 2026 44,57 М USD. EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od DocGo je bio 2025 31,75 М USD. Pad je time 40,38% viši u odnosu na prethodnu godinu.
Access this data via the Eulerpool API

DocGo Анализа акција

Šta radi DocGo? The history of DocGo Inc began in 2014 when the idea was born to develop a mobile app for doctor appointment scheduling and health monitoring. The founders recognized a rising demand for faster and more convenient access to medical services. From this vision, DocGo Inc was created. DocGo Inc's business model includes a range of mobile applications that improve access to medical care. The main application is DocGo, which allows users to book doctor appointments and track and manage their health data. This app also offers a feature for monitoring chronic conditions such as diabetes or high blood pressure and automatically sends reports on the status of these conditions to the user's doctor. Another important product from DocGo is the telemedicine system, which allows users to receive early assessments and diagnoses from doctors through video and chat. This helps avoid many cases where patients need to physically visit a doctor, saving time and money. DocGo has also developed a mobile pharmacy app that allows patients to order their medications directly through the app and have them delivered to their homes. This app also has interactive features such as a reminder function that notifies the user when to take their medications. Another important aspect of DocGo is its integration with wearables, which allows users to measure and send their health data to the app in real time. DocGo also utilizes artificial intelligence and machine learning to identify health risks in users and provide recommendations for medications and treatments. In recent years, DocGo has expanded in various areas. The company has formed partnerships with major healthcare organizations and hospitals to create a broader network of care. DocGo has also developed an API that allows other companies to integrate their health data into the DocGo system. Overall, DocGo has made a significant contribution to improving access to medical care, particularly during the COVID-19 pandemic. By providing telemedicine and mobile pharmacy services, as well as managing health data, DocGo has helped democratize and enhance healthcare. DocGo je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji DocGo

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) kompanije DocGo iznosi 44,57 М USD u 2026. godini.

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od DocGo se promijenio sa 31,75 М USD na 44,57 М USD, što predstavlja promjenu od 40,38%. Vrijednost je viši nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni historijski razvoj EBITDA (Заработак пре камата, пореза, амортизације и отписивања) DocGo od 2006. — sa godišnjim vrijednostima, grafikonima i detaljnom analizom.

EBITDA мери оперативну перформансу пре утицаја финансијске структуре, окружења пореза и не-готовинских отписивања.

EBITDA = EBIT + Амортизација и отписивање

EBITDA (Заработак пре камата, пореза, амортизације и отписивања)'s USD je ključan faktor za investitore. Promene u ovoj metrici mogu signalizirati poboljšane ili pogoršane fundamentalne faktore, direktno utiču na cenu akcije. Na Eulopoolu, možete pratiti EBITDA (Заработак пре камата, пореза, амортизације и отписивања)'s DocGo istorijski i u realnom vremenu.

Access this data via the Eulerpool API

Извештај о добити и губитку — DocGo

Sve ključne metrike — DocGo

Раст